Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: Evaluation of Evodial Hemodialyzer Selectivity Modifications (Evodial +) [NA]

View source ↗

Summary

This clinical trial evaluated selectivity modifications to the Evodial hemodialyzer (Evodial +) for end-stage renal disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evodial Hemodialyzer

Snippet

Sponsor: Vantive Health LLC | Conditions: End Stage Renal Disease (ESRD) | NA | Status: COMPLETED